FLAG Therapeutics develops cancer therapeutics using new classes of small molecules which have selective dual activity: antiangiogenesis and chemotherapeutic.
Company Location
9168 Wooden Road
Raleigh
NC
27617-8203
Phone
(919) 294-6472
County
Region
Company Details
Company type
Year founded
2013
Employment range in NC
US headquarters
North Carolina
Global headquarters
United States
Primary site activity
All company activities
Products under development
FLAG-003, a small molecule which has anti-angiogenic and anti-tubulin properties for the treatment of Glioma. FLAG also has a series of compounds which are GARFTase and SHMT-2 inhibitors, which are First-in-Class purine synthesis inhibitors.